RAHIKA 150MG TABLET

Introduction:

Rahika 150mg Tablet contains Capmatinib. It is used to treat non-small cell lung cancer (NSCLC). It is a disorder in which cells multiply in an uncontrolled and abnormal manner in the tissues of the lung. This medication is used in adult patients where the NSCLC cancer has spread to other parts of the body or cannot be removed by surgery and whose tumors have abnormal MET gene (mesenchymal-epithelial transition gene).

Before taking Rahika 150mg Tablet, you need to talk to your physician if you have or have had liver diseases or lung problems other than lung cancer. Use effective birth control during the treatment and for at least one week after the last dose. Limit sun exposure during the treatment with this medication. Use sunscreen or wear clothes that cover your skin while going outside. 

Uses of Rahika 150mg Tablet:

• Non-small cell lung cancer

How Rahika 150mg Tablet works:

Rahika 150mg Tablet targets the mesenchymal-epithelial transition (MET), block the signals that can increase cancer cell growth. This stops the growth of cancer cells.

Interactions with other drugs:

Inform your doctor about any medications you are taking or have taken before the treatment.

More information:

• Keep Rahika 150mg Tablet out of sight and reach of children. 
• Store at room temperature between 20°C to 25°C.

References:

1. Novartis Pharmaceuticals Corporation, US Food and Drug Administration, [ Revised on May 2020] [ Accessed on 11th Jan 2022], https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213591s000lbl.pdf
2. Jurgen Wolf et al; Capmatinib in MET Exon 14-Mutated or MET-Amplified Non-Small-Cell Lung Cancer; The New England Journal of Medicine; Published on 03/09/2020; Accessed on 11/01/2022; https://pubmed.ncbi.nlm.nih.gov/32877583/
3. Johan Filip Vansteenkiste et al; Capmatinib for the treatment of non-small cell lung cancer; Expert Review of Anticancer Therapy; Published on Aug 2019; Accessed on 11/01/2022; https://pubmed.ncbi.nlm.nih.gov/31368815/

How to use Rahika 150mg Tablet:

Always take Rahika 150mg Tablet exactly as your doctor has told you. You can take the tablet with or without food. Swallow the tablet whole with some water. Do not crush or chew the tablets. 

Safety advice:

Pregnancy:

Rahika 150mg Tablet can harm your unborn baby. Tell your doctor if you are pregnant or planning to get pregnant before taking this medicine.

Breastfeeding:

Do not breastfeed during the treatment and for at least 1 week after the last dose. Inform your doctor if you are breastfeeding before taking Rahika 150mg Tablet.

Liver:

You need to tell your doctor if you have any liver disorders before taking Rahika 150mg Tablet as this medication should be used with caution in liver disease patients. 

Driving: 

You may feel weak while being treated with Rahika 150mg Tablet. Avoid driving if you are unwell.

Others:

• Inform your physician if you have lung problems other than lung cancer before taking Rahika 150mg Tablet.
• Limit sun exposure during the treatment with this medication. Use sunscreen or wear clothes that cover your skin while going outside. 

Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.

Serious:

• Lung problems (cough, fever, or shortness of breath)
• Liver problems (yellowing of skin or whites of eyes, dark colored urine, confusion, light-colored stools)
• Risk of sensitivity to light

Common:

• Nausea, vomiting
• Tiredness, weakness
• Loss of appetite
• Swelling of hands or feet
• Changes in certain blood tests